---
document_datetime: 2025-07-28 14:24:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sephience-epar-all-authorised-presentations_en.pdf
document_name: sephience-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7620649
conversion_datetime: 2025-12-20 00:15:20.93458
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging    | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|------------------------|-------------|
| EU/1/25/1939/001 | Sephience         | 250 mg     | Oral powder           | Oral use                  | sachet (PET/PE/alu/PE) | 30 sachets  |
| EU/1/25/1939/002 | Sephience         | 1000 mg    | Oral powder           | Oral use                  | sachet (PET/PE/alu/PE) | 30 sachets  |